z-logo
open-access-imgOpen Access
Minibody-Indocyanine Green Based Activatable Optical Imaging Probes: The Role of Short Polyethylene Glycol Linkers
Author(s) -
Rira Watanabe,
Kazuhide Sato,
Hirofumi Hanaoka,
Toshiko Harada,
Takahito Nakajima,
Insook Kim,
Chang H. Paik,
Anna M. Wu,
Peter L. Choyke,
Hisataka Kobayashi
Publication year - 2014
Publication title -
acs medicinal chemistry letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.065
H-Index - 66
ISSN - 1948-5875
DOI - 10.1021/ml400533y
Subject(s) - indocyanine green , fluorophore , biodistribution , polyethylene glycol , conjugated system , peg ratio , fluorescence , covalent bond , fluorescence lifetime imaging microscopy , in vivo , molecular imaging , chemistry , biophysics , materials science , medicine , pathology , polymer , in vitro , biochemistry , organic chemistry , optics , physics , microbiology and biotechnology , finance , economics , biology
Minibodies show rapider blood clearance than IgGs due to smaller size that improves target-to-background ratio (TBR) in in vivo imaging. Additionally, the ability to activate an optical probe after binding to the target greatly improves the TBR. An optical imaging probe based on a minibody against prostate-specific membrane antigen (PSMA-MB) and conjugated with an activatable fluorophore, indocyanine green (ICG), was designed to fluoresce only after binding to cell-surface PSMA. To further reduce background signal, short polyethylene glycol (PEG) linkers were employed to improve the covalent bonding ratio of ICG. New PSMA-MBs conjugated with bifunctional ICG derivatives specifically visualized PSMA-positive tumor xenografts in mice bearing both PSMA-positive and -negative tumors within 6 h postinjection. The addition of short PEG linkers significantly improved TBRs; however, it did not significantly alter the biodistribution. Thus, minibody-ICG conjugates could be a good alternative to IgG-ICG in the optical cancer imaging for further clinical applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here